Close
| |

Home Page

Company Database

Licensing Deals

Investors

Latest updates

04 August 2015
Updates within the latest 30 days:

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next
Reset 

ABLYNX INITIATES PHASE II SLE STUDY WITH ITS ANTI-IL-6R NANOBODY, PARTNERED WITH ABBVIE

Read more ››
By: Nasdaq / GlobenewsWire - 04 Aug 2015
Related companies:  Ablynx nv

Pharma Sales to Grow Beyond $1 Trillion

PHILADELPHIA, Aug. 4, 2015 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals announced the... Read more ››

By: PR Newswire Association LLC. - 04 Aug 2015
Related companies:  Thomson Reuters | Thomson Reuters data analysis solutions

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 10, 2015

Read more ››
By: Nasdaq / GlobenewsWire - 03 Aug 2015
Related companies:  Novavax, Inc.

UNITE HERE calls on US Senate to Prevent Secret Pharma Money

LAS VEGAS, Aug. 3, 2015 /PRNewswire-USNewswire/ -- UNITE HERE sent letters this week to the Senate Committee on Health, asking Senators to put the brakes on a piece of legislation which would keep millions of... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015

BC Technical Acquires Ohio Valley Medical Systems

WEST JORDAN, Utah, Aug. 3, 2015 /PRNewswire/ -- BC Technical, the nation's leading non-OEM provider of Medical Imaging Solutions has acquired Ohio Valley Medical Systems, one of the largest MRI service providers specializing in Hitachi open MRI systems. The addition of Ohio Valley Medical Systems... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015

Entest BioMedical Inc.'s Zander Therapeutics Unit: Initial Focus is Small Molecule and Cancer Stem Targeting for Veterinary Oncology

SAN DIEGO, August 3, 2015 /PRNewswire/ -- Zander Therapeutics, a wholly owned subsidiary of Entest BioMedical Inc. (OTC: ENTBD), announced today its canine cancer therapeutics and feline leukemia platforms. These platforms will focus on adopting cutting edge technologies such as immune-oncology,... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015
Related companies:  Entest BioMedical, Inc.

Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call

GLENWOOD, Ill., Aug. 3, 2015 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today announced it will release financial... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015

AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results

REDWOOD CITY, Calif., Aug. 3, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today provided a business update and reported financial... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015
Related companies:  AcelRx Pharmaceuticals, Inc.

DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs

CUPERTINO, Calif., Aug. 3, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the second quarter of 2015. Total revenues were $4.4 million and net loss was $5.5 million for the three months ended June 30, 2015 as compared to total revenues of $4.6 million... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015
Related companies:  DURECT Corporation

Luminex Corporation Reports Record 2nd Quarter 2015 Results

AUSTIN, Texas, Aug. 3, 2015 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the second quarter ended June 30, 2015. Financial and operating highlights for the quarter include the following:

Read more ››
By: PR Newswire Association LLC. - 03 Aug 2015
Related companies:  Luminex Corporation

TeamHealth Acquires Brookhaven Anesthesia Associates; Expands New York Presence

KNOXVILLE, Tenn., Aug. 3, 2015 /PRNewswire/ -- Team Health Holdings, Inc. (NYSE: TMH), a leading provider of outsourced physician staffing solutions for hospitals, announced the acquisition of the operations of Brookhaven Anesthesia Associates. Based in Patchogue, New York, Brookhaven Anesthesia... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015

Diplomat Announces 2nd Quarter 2015 Financial Results

FLINT, Mich., Aug. 3, 2015 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter ended June 30, 2015. All comparisons, unless otherwise noted, are to the quarter ended June 30, 2014.

Read more ››
By: PR Newswire Association LLC. - 03 Aug 2015

Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates

WARRINGTON, Pa., Aug. 3, 2015 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, will host a live teleconference and webcast at 8:30 a.m. Eastern Time on Tuesday... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015
Related companies:  Discovery Laboratories, Inc.

Judith L. Coletti, MS, RN, is recognized by Continental Who's Who among Pinnacle Professionals

SALT LAKE CITY, Aug. 3, 2015 /PRNewswire/ -- Judith L. Coletti, MS, RN, is recognized by Continental Who's Who among Pinnacle Professionals in the field of Nursing. Judith is a (Retired) Registered Nurse and International Nurse Educator.

Read more ››
By: PR Newswire Association LLC. - 03 Aug 2015

Halozyme to Host Second Quarter 2015 Financial Results Conference Call

SAN DIEGO, Aug. 3, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2015 on Monday, August 10, 2015 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call.... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015
Related companies:  Halozyme Therapeutics, Inc.

BioScrip To Host 2015 Second Quarter Results Call

ELMSFORD, N.Y., Aug. 3, 2015 /PRNewswire/ -- BioScrip, Inc. (NASDAQ: BIOS) announced today that the Company will release its 2015 second quarter results on Monday, August 10, 2015 before the financial markets open.

Read more ››
By: PR Newswire Association LLC. - 03 Aug 2015
Related companies:  BioScrip, Inc.

Patient Guide: How to Prepare for Surgery

ROSEMONT, Ill., Aug. 3, 2015 /PRNewswire-USNewswire/ -- Your doctor has recommended surgery for your foot or ankle problem, and you're looking for the best possible outcome. Your orthopaedic foot and ankle specialist is looking for the best outcome too, and now there's a Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015

LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease

PARSIPPANY, N.J., Aug. 3, 2015 /PRNewswire/ -- LEO Pharma supports the recent decision by the U.S. Food and Drug Administration (FDA) to include psoriasis as one of eight priority disease areas in its 2016-2017 Patient Focused Drug Development Initiative(i). Psoriasis is an autoimmune... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015

Isis Reports Positive Data from KYNAMRO® (mipomersen sodium) FOCUS FH Phase 3 Study in Patients with Severe Heterozygous Familial Hypercholesterolemia

CARLSBAD, Calif., Aug. 3, 2015 /PRNewswire/ -- Isis Pharmaceuticals Inc. (NASDAQ: ISIS), today announced that the FOCUS FH phase 3 study of KYNAMRO(®) (mipomersen sodium) in patients with severe heterozygous familial hypercholesterolemia (severe HeFH) met its primary efficacy endpoint, a statistically... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015
Related companies:  Isis Pharmaceuticals, Inc.

Stuart Millheiser Discusses How the Different Causes of ALS Should Influence Treatment Plans

NEW YORK, Aug. 3, 2015 /PRNewswire-iReach/ -- Stuart Millheiser is the founder of ALS Guardian Angels, an organization that is dedicated to improving the lives ALS patients. The charity... Read more ››

By: PR Newswire Association LLC. - 03 Aug 2015
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next